

Publisher: Bentham Science Publishers
E-ISSN: 1875-533x|8|12|1505-1511
ISSN: 0929-8673
Source: Current Medicinal Chemistry, Vol.8, Iss.12, 2001-10, pp. : 1505-1511
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content








Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
Current Medicinal Chemistry, Vol. 18, Iss. 11, 2011-04 ,pp. :


Selective Histone Deacetylase Inhibitors with Anticancer Activity
Current Topics in Medicinal Chemistry, Vol. 16, Iss. 4, 2016-02 ,pp. :